News

Obesity drug prices are dropping, but getting a steady supply remains a challenge
Doctors say the situation forces them to get creative in treating patients, but there’s hope that prices may fall more in the ...
Eli Lilly's 3-step strategy to dominate the $95 billion obesity market
Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...
Doctors assumed my weight loss was because of Mounjaro - they missed the signs that it was actually colon cancer
The unnamed man has urged people taking weight loss injections to listen to their body and not let the fact they are taking ...
Exercise and a plant-based diet healthiest way to lose weight as compared to weight-loss drugs: Survey
As weight-loss drugs like semaglutide and tirzepatide dominate global headlines, a new nationwide survey shows that 87 per ...
Silo Pharma, Inc.: Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025
Planned submission of IND application in 2025; Phase 1 clinical trial to follow if IND application approved No new PTSD drug approvals in the U.S. in nearly 25 years; large potential addressable marke ...